MY102549A - Crystalline calcium pseudomonate and a process for preparing the same and its use as a pharmaceutical composition - Google Patents

Crystalline calcium pseudomonate and a process for preparing the same and its use as a pharmaceutical composition

Info

Publication number
MY102549A
MY102549A MYPI87001798A MYPI19871798A MY102549A MY 102549 A MY102549 A MY 102549A MY PI87001798 A MYPI87001798 A MY PI87001798A MY PI19871798 A MYPI19871798 A MY PI19871798A MY 102549 A MY102549 A MY 102549A
Authority
MY
Malaysia
Prior art keywords
preparing
pharmaceutical composition
same
crystalline calcium
calcium pseudomonate
Prior art date
Application number
MYPI87001798A
Other languages
English (en)
Inventor
Beal Merle
Harold Baker Geoffrey
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10562629&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY102549(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of MY102549A publication Critical patent/MY102549A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Electroluminescent Light Sources (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Cosmetics (AREA)
MYPI87001798A 1984-06-19 1987-09-21 Crystalline calcium pseudomonate and a process for preparing the same and its use as a pharmaceutical composition MY102549A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848415579A GB8415579D0 (en) 1984-06-19 1984-06-19 Compounds

Publications (1)

Publication Number Publication Date
MY102549A true MY102549A (en) 1992-07-31

Family

ID=10562629

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI87001798A MY102549A (en) 1984-06-19 1987-09-21 Crystalline calcium pseudomonate and a process for preparing the same and its use as a pharmaceutical composition

Country Status (27)

Country Link
US (5) US4916155A (enExample)
EP (1) EP0167856B1 (enExample)
JP (1) JPH0723373B2 (enExample)
KR (1) KR930002509B1 (enExample)
AT (1) ATE49600T1 (enExample)
AU (1) AU577595B2 (enExample)
CA (1) CA1242437A (enExample)
DE (1) DE3575428D1 (enExample)
DK (1) DK164506C (enExample)
ES (1) ES8604249A1 (enExample)
FI (2) FI84179C (enExample)
GB (1) GB8415579D0 (enExample)
GR (1) GR851470B (enExample)
HU (1) HU195515B (enExample)
IE (1) IE58118B1 (enExample)
IL (1) IL75536A (enExample)
JO (1) JO1420B1 (enExample)
MX (1) MX163401B (enExample)
MY (1) MY102549A (enExample)
NO (1) NO171593C (enExample)
NZ (1) NZ212433A (enExample)
PH (1) PH22951A (enExample)
PL (1) PL254033A1 (enExample)
PT (1) PT80657B (enExample)
YU (1) YU45724B (enExample)
ZA (1) ZA854549B (enExample)
ZM (1) ZM4185A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8415579D0 (en) * 1984-06-19 1984-07-25 Beecham Group Plc Compounds
GB8530796D0 (en) * 1985-12-13 1986-01-22 Beecham Group Plc Pharmaceutical composition
IE59628B1 (en) * 1986-06-26 1994-03-09 Beecham Group Plc Treatment of fungal infections
US5273998A (en) * 1990-05-11 1993-12-28 Yoshitomi Pharmaceutical Industries, Ltd. Process for making an optically active 3,4-dihydro-3,4-epoxy-2H-1-benzopyran compound
GB9507825D0 (en) * 1995-04-18 1995-05-31 Wet Pieter M De Method of treatment
GB9616208D0 (en) 1996-08-01 1996-09-11 Smithkline Beecham Plc Novel Compounds
CO4910145A1 (es) 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
IL129237A0 (en) * 1996-10-01 2000-02-17 Smithkline Beecham Corp Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms
GB9808470D0 (en) * 1998-04-22 1998-06-17 Smithkline Beecham Plc Novel process and apparatus
IL144679A0 (en) * 1999-02-03 2002-06-30 Teva Pharma Process for the preparation of pseudomonic acid a antibiotic by microbiological method
HRP20040051A2 (en) * 2001-06-21 2004-10-31 Biogal Gyogyszergyar Metabolic controlled fermentation process for pseudomonic acid production
JP2005516984A (ja) * 2001-12-28 2005-06-09 テバ ジョジセルジャール レースベニュタールシャシャーグ 結晶質及び非晶質ムピロシンカルシウムを生産する方法
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
US20040224981A1 (en) * 2003-05-01 2004-11-11 Nebojsa Janjic Antibacterial methods and compositions
US7589128B2 (en) * 2004-06-01 2009-09-15 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Process for preparation of amorphous form of a drug
CN101124221B (zh) * 2005-02-21 2012-05-23 克利亚制药股份公司 莫匹罗星的提纯方法
EP1879877B8 (en) 2005-05-03 2013-02-13 Ranbaxy Laboratories Limited Antimicrobial agents
EP1752516A1 (en) * 2005-08-01 2007-02-14 The Lubrizol Corporation Dispersants
GB2441328A (en) * 2006-08-30 2008-03-05 Alpharma Aps A method for obtaining mupirocin calcium
US20110015413A1 (en) * 2008-01-24 2011-01-20 Nafis Defterdarovic Process for preparing crystalline calcium mupirocin dihydrate
WO2010132833A1 (en) * 2009-05-14 2010-11-18 The Regents Of The University Of Michigan Streptococcus vaccine compositions and methods of using the same
WO2012014109A1 (en) 2010-07-30 2012-02-02 Ranbaxy Laboratories Limited Heterocyclic sulfonamides as inhibitors of transfer rna synthetase for use as antibacterial agents
WO2016133471A1 (en) 2015-02-20 2016-08-25 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A. Ş. A topical composition comprising mupirocin and dexpanthenol
KR102101297B1 (ko) 2019-02-15 2020-05-26 주식회사 드림테크 급속 스팀 세척기 제어방법
KR102269617B1 (ko) 2020-10-27 2021-06-24 신현호 스팀 급속제조장치 및 그 제어방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4071536A (en) * 1971-06-12 1978-01-31 Beecham Group Limited Antibiotics
GB1395907A (en) * 1971-06-12 1975-05-29 Beecham Group Ltd Antibiotics
GB1587058A (en) * 1976-06-15 1981-03-25 Beecham Group Ltd Oxiranylmethyltetrahydropyran derivatives
GB1577730A (en) * 1976-10-23 1980-10-29 Beecham Group Ltd Treatment of infections with pseudomonicacid salts or esters thereof
GB1577545A (en) * 1977-07-27 1980-10-22 Beecham Group Ltd Treatment of swine dysenter
CA1115699A (en) * 1978-05-20 1982-01-05 Alan D. Curzons Lithium pseudomonate and its preparation
GB2097670B (en) * 1981-03-11 1985-02-27 Beecham Group Ltd Growth promotor containing pseudomonic acid
GB8313035D0 (en) * 1983-05-12 1983-06-15 Beecham Group Plc Compound
GB8415579D0 (en) * 1984-06-19 1984-07-25 Beecham Group Plc Compounds
US4892960A (en) * 1985-01-28 1990-01-09 International Minerals & Chemical Corp. Crystalline lysocellin compositions and method of making

Also Published As

Publication number Publication date
FI88796B (fi) 1993-03-31
DK164506B (da) 1992-07-06
PT80657A (en) 1985-07-01
ES8604249A1 (es) 1986-01-16
NZ212433A (en) 1988-08-30
HU195515B (en) 1988-05-30
PT80657B (en) 1987-05-04
AU4373485A (en) 1986-01-02
ATE49600T1 (de) 1990-02-15
FI84179B (fi) 1991-07-15
IE851506L (en) 1985-12-19
ZA854549B (en) 1986-05-28
US4916155A (en) 1990-04-10
HUT38654A (en) 1986-06-30
FI88796C (fi) 1993-07-12
KR930002509B1 (ko) 1993-04-03
AU577595B2 (en) 1988-09-29
DE3575428D1 (de) 1990-02-22
CA1242437A (en) 1988-09-27
IL75536A0 (en) 1986-01-31
DK275585D0 (da) 1985-06-18
JPH0723373B2 (ja) 1995-03-15
FI913260A0 (fi) 1991-07-04
US5436266A (en) 1995-07-25
US5191093A (en) 1993-03-02
ZM4185A1 (en) 1985-11-22
EP0167856A2 (en) 1986-01-15
MX163401B (es) 1992-05-11
GB8415579D0 (en) 1984-07-25
FI852407A0 (fi) 1985-06-17
YU45724B (sh) 1992-07-20
DK275585A (da) 1985-12-20
JO1420B1 (en) 1986-11-30
KR860000291A (ko) 1986-01-27
DK164506C (da) 1992-11-23
NO852446L (no) 1985-12-20
FI852407L (fi) 1985-12-20
NO171593B (no) 1992-12-28
US5792790A (en) 1998-08-11
EP0167856A3 (en) 1986-11-26
IL75536A (en) 1989-01-31
EP0167856B1 (en) 1990-01-17
ES544329A0 (es) 1986-01-16
PL254033A1 (en) 1986-04-22
FI84179C (fi) 1991-10-25
IE58118B1 (en) 1993-07-14
US5569672A (en) 1996-10-29
YU101385A (en) 1988-02-29
NO171593C (no) 1993-04-07
PH22951A (en) 1989-02-03
GR851470B (enExample) 1985-11-25
JPS6117583A (ja) 1986-01-25

Similar Documents

Publication Publication Date Title
MY102549A (en) Crystalline calcium pseudomonate and a process for preparing the same and its use as a pharmaceutical composition
ZA894128B (en) Use of gamma-hydroxybutryic acid salts for preparing pharmaceutical compositions for use in the treatment of alcoholism,and the compositions obtained
ES478047A1 (es) Procedimiento para la obtencion de acidos 4-piridon-3-car- boxilicos.
IL55429A0 (en) Thiadiaolyl cephalosporin analogs, processes for the preparation thereof,pharmaceutical or veterinary compositions containing the same and method of inhibiting the growth of bacteria therewith
ATE110745T1 (de) Wachstumshormonkristalle und verfahren zu deren herstellung.
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
MY101747A (en) Dihydroorotic acids derivative, processes for preparing the same
IL91152A0 (en) Furylthiazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL84889A0 (en) Salts of pyrophosphorous acid,their preparation and their use as microbicides
EP0248736A3 (en) Substituted benzimidazolylthiomethyl benzothiazole derivatives and their salts, process for their preparation, their medical application and compositions containing them
IL70621A0 (en) Fluoroazolylpropane derivatives,their preparation and their use as microbicides and plant growth regulants
EP0347459A4 (en) CEPHALOSPORIN COMPOUNDS OR SALTS THEREOF, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS.
IL69646A0 (en) Phenoxyalkanoic acid derivatives,their preparation and use for regulating plant growth
ZA871059B (en) Novel antibiotics of the streptogramin type,a microbiological process for their preparation and their use as medicaments and feed additives
ZA886870B (en) L-dopa derivatives or their acid addition salts,process for producing same and their use
HU9201315D0 (en) Process for the production of medical preparations containing 4-/n,n-dibenzyl-amino/-butyric acid or butyric amid as active agent, or their medically useful salts